February 3, 2013 — Los Angeles, CA (PRWEB) March 06, 2012
NEWtritious™ Functional Foods & Beverages and Medicus Research Set a New Precedent in Clinical Studies Protocol
NEWtritious™ Functional Foods & Beverages and Medicus Research announced today that they have filed documents with the IRB (Internal Review Board) overseeing the study, officially beginning the clinical trial for the Kherb Appeal™ weight loss formulation.
Utilizing a progressive new protocol for providing accuracy and authenticity in clinical study compliance, the parallel studies will test the NEWtritious™ Kherb Appeal™ weight loss product to demonstrate its efficacy on weight loss and satiety as a snack replacement for dieters, while improving metabolic functions regarding lipids and blood glucose levels.
The goal is to establish Kherb Appeal™ as a functional food proving that this synergistic matrix of ingredients will be the new paradigm for healthy weight loss, and institute a much-needed accurate standard for clinical trials now and in the future.
Mechanisms Associated with Weight Loss in Kherb Appeal™
- ✓Increasing satiety
- ✓Delayed gastric emptying
- ✓Balancing gut flora
- ✓Increasing insulin sensitivity
- ✓Inhibiting fatty acid production
- ✓Reduction of triglycerides
- ✓Reduction of lipids
Medicus Research designed the SysteMedicus technologies to visibly prove accuracy and compliancy through a real-time recording on Apple® mobile devices including iPads and iPods. The patent pending SysteMedicus technologies include eConsent, eSource and eCompliance technologies which all ensure that the information is collected according to the FDA ALCOA standards (accurate, legible, contemporaneous, original, and attributable).
The Kherb Appeal™ randomized, double-blind, placebo-controlled, parallel-group, adaptive design study will evaluate the efficacy of the Kherb Appeal™ product compared to a placebo, to establish weight loss and satiety for an overweight and obese population as well as in a population with impaired glucose tolerance. The 14-week study will include 160 participants.